Optogenetic-controlled immunotherapeutic designer cells for post-surgical cancer immunotherapy

Surgical resection is the main treatment option for most solid tumors, yet cancer recurrence after surgical resection remains a significant challenge in cancer therapy. Recent advances in cancer immunotherapy are enabling radical cures for many tumor patients, but these technologies remain challengi...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Yuanhuan, Wu, Xin, Wang, Meiyan, Liu, Wenjing, Zhang, Li, Zhang, Ying, Hu, Zhilin, Zhou, Xuantong, Jiang, Wenzheng, Zou, Qiang, Cai, Fengfeng, Ye, Haifeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9605972/
https://www.ncbi.nlm.nih.gov/pubmed/36289204
http://dx.doi.org/10.1038/s41467-022-33891-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9605972/
https://www.ncbi.nlm.nih.gov/pubmed/36289204
http://dx.doi.org/10.1038/s41467-022-33891-9

Ejemplares similares